NRX Pharmaceuticals, Inc. Form D filing
Biotech · Series A · Regulation D 506(b) · DE · Filed March 7, 2025
View all SEC Form D filings for NRX Pharmaceuticals, Inc.- Offering amount
- $3.5M
- Exemption
- Reg D 506(b)
- Filing type
- Form D
- Form D industry group
- Not disclosed
- Issuer state
- DE
- Filing date
- March 7, 2025
- Signature date
- March 6, 2025
- CIK
- 0001719406
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Filing snapshot
NRX Pharmaceuticals, Inc. (based in DE) filed an SEC Form D filing on March 7, 2025, disclosing a $3.5M offering of securities under Rule 506(b) of Regulation D. FormDFlow has tagged the issuer's sector as Biotech. This page reflects the public filing as recorded in SEC EDGAR; see the source document for the complete disclosure.
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.